Fujii et al., 2011 - Google Patents
Genotoxicity and subchronic toxicity evaluation of Active Hexose Correlated Compound (AHCC)Fujii et al., 2011
View PDF- Document ID
- 14313544293133581278
- Author
- Fujii H
- Nishioka N
- Simon R
- Kaur R
- Lynch B
- Roberts A
- Publication year
- Publication venue
- Regulatory Toxicology and Pharmacology
External Links
Snippet
Active Hexose Correlated Compound (AHCC), a mushroom extract rich in α-1, 4 linked glucans, is associated with immunostimulatory effects. AHCC is used in Japan as a dietary supplement to boost immune function and it also is purported to improve the symptoms of …
- 150000001875 compounds 0 title abstract description 22
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Fujii et al. | Genotoxicity and subchronic toxicity evaluation of Active Hexose Correlated Compound (AHCC) | |
| De la Guardia et al. | Handbook of mineral elements in food | |
| Vignal et al. | Gut: An underestimated target organ for Aluminum | |
| Mellert et al. | Thirteen-week oral toxicity study of synthetic lycopene products in rats | |
| Nakajima et al. | An evaluation of the genotoxicity and subchronic toxicity of the peel extract of Ponkan cultivar ‘Ohta ponkan’(Citrus reticulata Blanco) that is rich in nobiletin and tangeretin with anti-dementia activity | |
| Song et al. | Dietary supplementation with selenium nanoparticles-enriched Lactobacillus casei ATCC 393 alleviates intestinal barrier dysfunction of mice exposed to deoxynivalenol by regulating endoplasmic reticulum stress and gut microbiota | |
| Han et al. | Acute and 28-day subacute toxicity studies of hexane extracts of the roots of Lithospermum erythrorhizon in Sprague-Dawley rats | |
| Prasad | Zinc in human nutrition | |
| Deshmukh et al. | Citrus aurantium (bitter orange) extract: Safety assessment by acute and 14-day oral toxicity studies in rats and the Ames Test for mutagenicity | |
| Tomaszewska et al. | The lack of protective effects of tea supplementation on liver and jejunal epithelium in adult rats exposed to cadmium and lead | |
| Garcia et al. | Hematological effects of arsenic in rats after subchronical exposure during pregnancy and lactation: the protective role of antioxidants | |
| Azuma et al. | Preventive effect of soybean resistant proteins against experimental tumorigenesis in rat colon | |
| Wong et al. | Oral subchronic and genotoxicity studies conducted with the amino acid, L-glutamine | |
| Welberg et al. | Effects of oral calcium supplementation on intestinal bile acids and cytolytic activity of fecal water in patients with adenomatous polyps of the colon | |
| Zhang et al. | Toxicological evaluation of New Zealand deer velvet powder. Part I: acute and subchronic oral toxicity studies in rats | |
| Libinaki et al. | Evaluation of the safety of mixed tocopheryl phosphates (MTP)—A formulation of α-tocopheryl phosphate plus α-di-tocopheryl phosphate | |
| RU2580314C1 (en) | Method for treatment and prevention of glomerular and tubulointerstitial kidney disease in children, associated with toxic effect of cadmium, lead, chromium and phenol of technogenic origin | |
| Jin et al. | Subchronic oral toxicity evaluation of sodium dehydroacetate: a 90-day repeated dose study in rats | |
| Lee et al. | Safety evaluation of cricket (Gryllus bimaculatus) extract in Sprague-Dawley rats | |
| Dostal et al. | Effects of nickel chloride on lactating rats and their suckling pups, and the transfer of nickel through rat milk | |
| Okado et al. | Safety evaluation of AMP deaminase from Aspergillus oryzae | |
| Akpantah et al. | The effect of calabash chalk on some hematological parameters in female adult Wistar rats | |
| Mellert et al. | Carcinogenicity and chronic toxicity of copovidone (Kollidon VA 64) in Wistar rats and Beagle dogs | |
| RU2506084C1 (en) | Drug preparation for prevention and treatment of hypovitaminosis and normalisation of metabolism in poultry | |
| JP2011037790A (en) | Liver function-enhancing agent and functional food |